201 related articles for article (PubMed ID: 34180947)
1. Effect of Oral Ranitidine on Urinary Excretion of N-Nitrosodimethylamine (NDMA): A Randomized Clinical Trial.
Florian J; Matta MK; DePalma R; Gershuny V; Patel V; Hsiao CH; Zusterzeel R; Rouse R; Prentice K; Nalepinski CG; Kim I; Yi S; Zhao L; Yoon M; Selaya S; Keire D; Korvick J; Strauss DG
JAMA; 2021 Jul; 326(3):240-249. PubMed ID: 34180947
[TBL] [Abstract][Full Text] [Related]
2. Oral intake of ranitidine increases urinary excretion of N-nitrosodimethylamine.
Zeng T; Mitch WA
Carcinogenesis; 2016 Jun; 37(6):625-634. PubMed ID: 26992900
[TBL] [Abstract][Full Text] [Related]
3. A Bioanalytical Method for Quantification of N-nitrosodimethylamine (NDMA) in Human Plasma and Urine with Different Meals and following Administration of Ranitidine.
De Palma R; Patel V; Florian J; Keire D; Selaya D; Strauss DG; Rouse R; Matta MK
J Pharm Sci; 2023 May; 112(5):1315-1323. PubMed ID: 36736776
[TBL] [Abstract][Full Text] [Related]
4. In Vitro Analysis of N-Nitrosodimethylamine (NDMA) Formation From Ranitidine Under Simulated Gastrointestinal Conditions.
Gao Z; Karfunkle M; Ye W; Marzan TA; Yang J; Lex T; Sommers C; Rodriguez JD; Han X; Florian J; Strauss DG; Keire DA
JAMA Netw Open; 2021 Jun; 4(6):e2118253. PubMed ID: 34181009
[TBL] [Abstract][Full Text] [Related]
5. Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression.
Abdul-Hussein M; Freeman J; Castell D
Pharmacotherapy; 2015 Dec; 35(12):1124-9. PubMed ID: 26621819
[TBL] [Abstract][Full Text] [Related]
6. Effect of ascorbic acid and green tea on endogenous formation of N-nitrosodimethylamine and N-nitrosopiperidine in humans.
Vermeer IT; Moonen EJ; Dallinga JW; Kleinjans JC; van Maanen JM
Mutat Res; 1999 Jul; 428(1-2):353-61. PubMed ID: 10518007
[TBL] [Abstract][Full Text] [Related]
7. Urinary excretion of nitrosodimethylamine and nitrosoproline in humans: interindividual and intraindividual differences and the effect of administered ascorbic acid and alpha-tocopherol.
Garland WA; Kuenzig W; Rubio F; Kornychuk H; Norkus EP; Conney AH
Cancer Res; 1986 Oct; 46(10):5392-400. PubMed ID: 3756889
[TBL] [Abstract][Full Text] [Related]
8. N-nitrosodimethylamine (NDMA) contamination of ranitidine products: A review of recent findings.
Aldawsari FS; Alshehry YM; Alghamdi TS
J Food Drug Anal; 2021 Mar; 29(1):39-45. PubMed ID: 35696227
[TBL] [Abstract][Full Text] [Related]
9. A lack of pharmacokinetic interaction between ranitidine and piroxicam.
Dixon JS; Lacey LF; Pickup ME; Langley SJ; Page MC
Eur J Clin Pharmacol; 1990; 39(6):583-6. PubMed ID: 1982764
[TBL] [Abstract][Full Text] [Related]
10. Ranitidine (Zantac) syrup versus Ranitidine effervescent tablets (Zantac) EFFERdose) in children: a single-center taste preference study.
Ameen VZ; Pobiner BF; Giguere GC; Carter EG
Paediatr Drugs; 2006; 8(4):265-70. PubMed ID: 16898856
[TBL] [Abstract][Full Text] [Related]
11. N-Nitrosodimethylamine (NDMA) Formation from Ranitidine Impurities: Possible Root Causes of the Presence of NDMA in Ranitidine Hydrochloride.
Yokoo H; Yamamoto E; Masada S; Uchiyama N; Tsuji G; Hakamatsuka T; Demizu Y; Izutsu KI; Goda Y
Chem Pharm Bull (Tokyo); 2021; 69(9):872-876. PubMed ID: 34470951
[TBL] [Abstract][Full Text] [Related]
12. Temperature-Dependent Formation of N-Nitrosodimethylamine during the Storage of Ranitidine Reagent Powders and Tablets.
Abe Y; Yamamoto E; Yoshida H; Usui A; Tomita N; Kanno H; Masada S; Yokoo H; Tsuji G; Uchiyama N; Hakamatsuka T; Demizu Y; Izutsu KI; Goda Y; Okuda H
Chem Pharm Bull (Tokyo); 2020 Oct; 68(10):1008-1012. PubMed ID: 32779580
[TBL] [Abstract][Full Text] [Related]
13. Comparative bioavailability of two oral formulations of ranitidine.
Flores-Murrieta FJ; Toledo A; del Carmen Carrasco-Portugal M; Reyes-García G; Rodríguez-Silverio J; Medina-Santillán R; Herrera JE
Biopharm Drug Dispos; 2006 Jan; 27(1):23-7. PubMed ID: 16278926
[TBL] [Abstract][Full Text] [Related]
14. Polyethylene glycol 400 enhances the bioavailability of a BCS class III drug (ranitidine) in male subjects but not females.
Ashiru DA; Patel R; Basit AW
Pharm Res; 2008 Oct; 25(10):2327-33. PubMed ID: 18600434
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of bismuth and ranitidine following multiple doses of ranitidine bismuth citrate.
Koch KM; Kerr BM; Gooding AE; Davis IM
Br J Clin Pharmacol; 1996 Aug; 42(2):207-11. PubMed ID: 8864319
[TBL] [Abstract][Full Text] [Related]
16. Ranitidine: A Proposed Mechanistic Rationale for NDMA Formation and a Potential Control Strategy.
Harmon P
J Pharm Sci; 2023 May; 112(5):1220-1224. PubMed ID: 36384193
[TBL] [Abstract][Full Text] [Related]
17. Dietary intakes of nitrate, nitrite and NDMA in the Finnish Mobile Clinic Health Examination Survey.
Dich J; Järvinen R; Knekt P; Penttilä PL
Food Addit Contam; 1996 Jul; 13(5):541-52. PubMed ID: 8799716
[TBL] [Abstract][Full Text] [Related]
18. In-vivo formation of N-nitrosodimethylamine in humans after amidopyrine intake.
Spiegelhalder B; Preussmann R
IARC Sci Publ; 1984; (57):179-83. PubMed ID: 6533005
[TBL] [Abstract][Full Text] [Related]
19. In vivo inhibition of N-nitrosodimethylamine metabolism by 4-methylpyrazole: a model for endogenous nitrosation.
Perciballi M; Hotchkiss JH
Carcinogenesis; 1989 Dec; 10(12):2303-9. PubMed ID: 2591019
[TBL] [Abstract][Full Text] [Related]
20. Understanding and Preventing (
White CM
Ann Pharmacother; 2020 Jun; 54(6):611-614. PubMed ID: 31771343
[No Abstract] [Full Text] [Related]
[Next] [New Search]
